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Abstract
For Genetic Analysis Workshop 16 Problem 1, we provided data for genome-wide association
analysis of rheumatoid arthritis. Single-nucleotide polymorphism (SNP) genotype data were
provided for 868 cases and 1194 controls that had been assayed using an Illumina 550 k platform. In
addition, phenotypic data were provided from genotyping DRB1 alleles, which were classified
according to the rheumatoid arthritis shared epitope, levels of anti-cyclic citrullinated peptide, and
levels of rheumatoid factor IgM. Several questions could be addressed using the data, including
analysis of genetic associations using single SNPs or haplotypes, as well as gene-gene and genetic
analysis of SNPs for qualitative and quantitative factors.
Background
Rheumatoid arthritis is a complex disease with a
moderately strong genetic component. The recurrence
risk ratio for siblings is typically estimated at around 6 in
Caucasians, but it has a broad range of values, primarily
because the prevalence in the population is not well
characterized [1]. The prevalence also varies among
populations, ranging from around 0.8% in Caucasians to
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Open Access10% in some Native American groups. Females are
generally at higher risk than males, with about a 3 to 1
predominance of females to males. The mean age of
disease onset is in the fifth decade with considerable
variability in age at presentation, including occasional
presentation in the teenage years.
The HLA region on 6p21 has been implicated by
numerous studies, and there is consistent evidence that
DR alleles contribute to disease risk. The ‘shared epitope’
hypothesis was proposed by Gregersen et al. [2] to
explain the organization of risk for rheumatoid arthritis
from DR alleles. According to this hypothesis, indivi-
duals who share a QK/RRAA motif in positions 70 to 74
of the DR molecule show an increased risk for disease.
The alleles that confer increased risk for rheumatoid
arthritis include DRB1*0101, 0102, 0104, 0105, 0401,
0404, 0405, 0408, 0409, 1001, 1402,a n d1406,w i t h
highest risk alleles in bold [3]. This model was not quite
sufficient to explain risk according to DR types, and
newer models utilizing data from positions 70 to 74
have been developed [4,5]. DR effects on risk for
rheumatoid arthritis also show a complex effect on risk
for rheumatoid arthritis, but presence of two risk alleles
generally increases risk substantially more than the risk
associated with heterozygosity for risk and nonrisk
alleles. Aside from the main effects of DR, there is also
evidence for interactions with other HLA loci or
haplotypic effects including the class 1 region and the
central MHC [6]. Certain DR alleles, notably DR3 [7,8],
can occur on a background of extended linkage
disequilibrium, for which the extended haplotype con-
fers increased risk, even though DR3 alleles alone do not
increase risk.
Two quantitative phenotypes that are used for identify-
ing rheumatoid arthritis affected individuals include
anti-cyclic citrullinated peptide (anti-CCP) and rheuma-
toid factor IgM autoantibodies. The heritability of these
measures is hard to obtain from the selected sib pairs we
are studying. After proband correction, the heritability
estimates are 11% and 30%, while before correction the
heritabilities are 15% and 67%. Specific autoantibodies
are noted to co-occur with rheumatoid arthritis. Rheu-
matoid factor IgM has been correlated with erosive
arthritic disease. However, anti-CCP is more specific for
the disease and is a better predictor of erosive outcome
[9]. Elevations of anti-CCP have been noted to predict
increased risk for development of rheumatoid arthritis
[10]. The shared-epitope alleles are strongly associated
with the presence of anti-CCP antibodies, and there is
evidence that this effect is modulated by HLA-DR3 [8].
Alleles at the PTPN22 locus have been shown to confer
an increased risk for rheumatoid arthritis [11]. At least
two alleles of PTPN22 have been implicated as causing
increased risk for rheumatoid arthritis; the R620W allele
in rs2476601 (hCV16021387) confers 1.7- to 1.9-fold
increased risk to heterozygotes and higher risks to
homozygous carriers. These findings have further been
confirmed by analysis of transmission of PTPN22 alleles
to affected offspring in families [12]. Increased risk has
also been noted for either hCV8689108 or
hCV25762283 [13], with some indeterminacy because
of linkage disequilibrium among these markers (and
others in the region).
The CTLA4 locus on chromosome 2q33 has been
associated with mildly increased risk for rheumatoid
arthritis [14]. In addition, alleles at loci in the TRAF1/C5
region are associated with rheumatoid arthritis risk [15].
A targeted association study showed that alleles of STAT4
[16] are associated with rheumatoid arthritis risk, but
these associations are too weak to reach genome-wide
levels of association in the data set that we have here
provided. Similarly, a locus on chromosome 6q
(TNFAIP3) that is associated with rheumatoid arthritis
risk has relatively weaker effects [15]. Additional loci that
have been implicated in Caucasian rheumatoid arthritis
populations include CD40 (20q13), PRKCQ (10p15),
and CCL21 (9p13), among others [17,18].
Aside from identified genetic factors and sex, few
environmental cofactors have been identified as affecting
risk for rheumatoid arthritis. However, current smoking
confers about a two-fold increased risk [7]. Klareskog
et al. [19] showed that the risk from smoking for
rheumatoid arthritis is particularly high among indivi-
duals who have a shared-epitope allele and who also
have elevated levels of anti-CCP antibodies. The biolo-
gical basis for this rather complex interaction appears to
reflect increased citrullination of peptides among smo-
kers, and presentation of citrullinated peptides by
shared-epitope alleles.
The data set submitted for the Genetic Analysis Work-
shop 16 (GAW16) was designed with a primary goal of
allowing the identification of genetic factors that
predispose to rheumatoid arthritis using association
methods. Given some previously identified evidence
for effects of smoking on rheumatoid arthritis risk and
difference in risk according to sex, there is an interest in
identifying gene-environment and gene-gene combina-
tions that yield particularly high risks to individuals for
rheumatoid arthritis.
Methods
The cases that we made available for analysis by
participants in GAW16 comprised independent
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Rheumatology criteria for rheumatoid arthritis. These
cases comprise a single member of 445 sibpairs that were
studied as a part of the North American Rheumatoid
Arthritic Consortium because they had at least one
additional sibling with rheumatoid arthritis, and an
additional 423 cases who were not selected for family
history. The cases were recruited from across the United
States. Cases are predominantly of Northern European
origin. The controls, derived from the New York Cancer
Project, were enrolled in the New York metropolitan area
[20]. These controls are somewhat enriched for indivi-
duals of Southern European or Ashkenazi Jewish
ancestry compared with cases. Structure across European
populations has been described [21,22], and some
autoimmune predisposing alleles, such as the PTPN22
R620W and HLA DR4 alleles show strong clines across
European populations. In addition, alleles at other loci
such as the Lactase Persistence gene (LCT) show strong
clines across European populations. Evidence in associa-
tion studies for an effect of the LCT locus on case/control
status likely reflects false-positive association due to
stratification. Studies within Europe have confirmed the
associations of PTPN22 and HLA but have not confirmed
effects of LCT on risk for rheumatoid arthritis.
The GAW16 rheumatoid arthritis data is part of ongoing
studies to identify genetic associations of rheumatoid
arthritis [14]. The data that were provided to GAW16
included results from genotyping 868 cases and 1194
controls after the application of quality control proce-
dures that included removing individuals who had a low
overall call rate (<95%) of single-nucleotide polymorph-
isms (SNPs), removing first degree relatives, and remov-
ing duplicated and contaminated samples. The data that
were provided as a part of Genetic Analysis Workshop 16
Problem 1 were included in a previous publication [15],
which identified the TRAF1/C5 locus as contributing to
susceptibility to rheumatoid arthritis. This earlier pub-
lication included additional data that were not provided
to the Genetic Analysis Workshop 16 Problem 1 from a
study of early-onset rheumatoid arthritis conducted in
Sweden. Aside from the TRAF1/C5 locus, there were
significant effects from the HLA region and PTPN22 that
can be readily discerned from the data.
Data that were provided to Genetic Analysis Workshop
16 participants included affection status with rheuma-
toid arthritis, sex, DRB1 alleles detected by serology and
further defined using DNA probes for DRB1*04 and
DRB1*01 alleles, number of shared epitopes carried, the
anti-CCP titer, rheumatoid factor IgM level, and 545,080
genotypes derived from Illumina genotyping arrays. All
rheumatoid arthritis cases and 589 controls were
genotyped on the HumanHap500 v1, 358 controls
were done on the Human Hap500 v3.0, and 247
controls were done on HumanHap300 and Human-
Hap240 arrays.
Discussion
Rheumatoid arthritis results from a complex interaction
of genetic and environmental factors. Data that were
provided for GAW16 were derived from a large number
of cases and controls who had been genotyped using
dense SNP arrays. These data were sufficient to identify
many genetic loci influencing rheumatoid arthritis risk.
In addition, we provided data for two autoantibodies
that are often elevated among individuals who have
rheumatoid arthritis. Aside from identifying genetic
factors influencing rheumatoid arthritis, the data that
were provided can be used to investigate population
structure in European populations, methods for inferring
SNPs, and modeling approaches when multiple genetic
factors influence disease risk.
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